Multiple reports highlight a new study finding an association between low blood pressure and a higher risk of developing Alzheimer’s disease. The outlets describe Alzheimer’s as the most common form of dementia and note its impact in the UK, including that more than 520,000 people are living with the condition. The claim in the coverage is that low blood pressure substantially increases the likelihood of later Alzheimer’s, with one report stating the risk “triples.” The articles, however, provide limited methodological detail in the excerpts available, including how “low blood pressure” is defined, the size and characteristics of the study population, and whether the analysis adjusts for factors that could also influence dementia risk. The coverage therefore centers on the reported risk increase while offering only general context about Alzheimer’s prevalence. Overall, the sources agree on the central message: the study reports a significant link between low blood pressure and later Alzheimer’s disease risk, and the UK carries a large and growing burden of Alzheimer’s.
Study links low blood pressure with increased risk of developing Alzheimer’s
Multiple reports highlight a new study finding an association between low blood pressure and a higher risk of developing Alzheimer’s disease. The outlets describe Alzheimer’s as the most common form o...
- The reported study finds an association between low blood pressure and higher risk of developing Alzheimer’s disease.
- One report states the risk “triples.”
- Alzheimer’s is described as the most common form of dementia.
- The articles say more than 520,000 people in the UK have Alzheimer’s.
- Alzheimer’s is described as a leading cause of death in the UK.
More than 520,000 Britons have Alzheimer's - the most common form of dementia, which is the UK's leading cause of death.
15 hours agoMore than 520,000 Britons have Alzheimer's - the most common form of dementia, which is the UK's leading cause of death.
15 hours agoScientific American’s “COVID, Quickly” podcast tracks vaccines, variants, and evolving public-health guidance
Scientific American’s “COVID, Quickly” podcast, hosted by senior health editors Tanya Lewis and Josh Fischman, provides...
60-Second Science audio soundscapes feature Amazon animal calls
In its latest “Sound(E)scapes” episodes, 60-Second Science presents an audio immersion into the Amazon rainforest, offer...
UK MHRA approves Wegovy’s first GLP-1 weight-loss tablet
The UK’s medicines regulator, the MHRA, approves the first tablet form of a GLP-1 receptor agonist for weight loss. The...